Respiratory & Nasal Care OTC Stocks - Financial Analysis & Market Data

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (4)

Company	Market Cap	Price
HLN Haleon plc Respiratory Health OTC products are part of Haleon's consumer health portfolio.	$45.98B	$10.14 +0.70%
RDY Dr. Reddy's Laboratories Limited OTC respiratory & nasal care products within consumer health segment.	$11.95B	$14.17 -1.25%
PRGO Perrigo Company plc Respiratory & Nasal Care OTC products are part of Perrigo's consumer self-care lineup.	$1.30B	$9.43 +0.05%
AMPH Amphastar Pharmaceuticals, Inc. BAQSIMI and Primatene MIST anchor respiratory/nasal care and OTC/inhalation product categories.	$835.18M	$17.81 -2.01%

Loading company comparison...

Loading industry trends...

Loading research report...

Haleon Invests £65 Million in New Shanghai Oral‑Health Manufacturing Facility

RDY Dr. Reddy's Laboratories Limited

FDA Issues Voluntary Action Indicated Inspection Report for Dr. Reddy’s Laboratories Srikakulam Facility

AMPH Amphastar Pharmaceuticals, Inc.

Amphastar Reports Q4 2025 Earnings Missed Estimates, Highlights Pricing Pressure and Product‑Mix Shift

PRGO Perrigo Company plc

Perrigo Reports Fourth‑Quarter and Fiscal 2025 Results, Misses EPS Estimate, Maintains FY2026 Guidance

Haleon plc Reports Q4 2025 Earnings: Revenue Misses Guidance, Strong Margins, Cautious 2026 Outlook

AMPH Amphastar Pharmaceuticals, Inc.

Amphastar Secures FDA Approval for Ipratropium Bromide HFA Inhaler, Gaining 180‑Day Exclusivity

RDY Dr. Reddy's Laboratories Limited

Dr. Reddy’s Receives FDA Acceptance for Abatacept Biosimilar BLA, Advancing Interchangeable Biosimilar Strategy